Shandong Baofa Oncotherapy Corporation Limited erat statutum in December MMII, Registered Capital of Sexaginta million Mirum Yuan. In comitatu est subordinata unitatum Taimei Baofa Tumor Hospital, Jinan Occidentem urbe Hospitalis (Jinan Boofa Cancer Hospital), Beijing Baifa Cancer Hospital, Jinan Yoke Medical Technology Cancer Hospital, Jinan Yoke Medical Technology Co., Ltd et in.
Chafman de Shandong Baofa Oncotherapy Corporation Limited est Professor Yu Baofa quis est decima National Populi Congresso, CPPC sodales Jinan urbe, quod celebre Americae rediit cancer Lorem.
In MCMXCVIII Professor Yubaofa condita in Taimei Baofa Tumor hospitalis in Dongping, in hospitium totalis investment de XXX decies Yuan, nunc certa bonorum plus quam L decies Yuan, et cum international ad provectus Cancer Domus Directory, et cum Describe Domestica.
In MMIV Professor Yubaofa et condita Jinan cancer hospitium in Jinan. In hospitium nunc portare e "tardus release Lorem", "activation Rectum", "activation Chemotherapy", "Psychotherapy", "Modern Cancer Treatment, deficiente" et multi moderni cancer Chinese ", et totus corporis, medii et sera, de integrated, medii et serum, deficiente totius corporis, medii et serum gradu, et totus corporis, mediam et serum scaena tumores. Quod "tardus release Lorem Lorem" signature therapies quod inventa ab Professor Yubaofa, quae adeptus est United States, Sina, Australia III National Invention Patentes. The "Slow Release Storage Therapy" has successfully treated more than 10,000 cancer patients where from more than 30 provinces and cities including Hong Kong, Macao and Taiwan, the autonomous regions and special administrative regions and the United States, Russia, Canada, Japan, Singapore, South Africa and other 11 countries, and achieved good results, for the majority of cancer patients relieve pain, have created one after another life miracle.
Nam latius progressionem medicinae et sanitas servicia, in comitatu in November I, MMXII condita Beijing Baijing Beijing Cancer hospitalis in Beijing, fretus in capite scriptor convenient negotiationis conditionibus, ita ut magis cancer aegris potest esse magis opportune, ita ut magis cancer aegris potest esse magis opportune, ita ut magis cancer aegros potest esse, ita ut magis admodum cancer aegros potest esse, ita ut magis Cancer est, ut magis admodum, ita ut magis Cancer aegros potest esse, ita ut magis Cancer est, ut magis admodum, ut magis admodum cancer est, ut magis opportunius, ut magis Cancer est, ut magis admodum, ita ut magis Cancer est, ut magis opportunius, ita ut magis cancer aegris potest esse, ita ut magis admodum cancer aegris potest esse magis opportune 'Evangelium.